Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Poplack

Showing results (11-20 of 227) with videos related to

Pageof 23
Sort By:
Investigational New Drugs|January 1, 1996
Pharmacologic strategies for the treatment of meningeal malignancyS M Blaney, D G Poplack
Medical and Pediatric Oncology|January 1, 1979
Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoirW A Bleyer, D G Poplack
Current Opinion in Oncology|January 1, 1996
Central nervous system leukemiaS M Blaney, D G Poplack
Journal of Neuro-Oncology|August 8, 1998
New cytotoxic drugs for intrathecal administrationS M Blaney, D G Poplack
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Central nervous system pharmacology of antileukemic drugsF M Balis, D G Poplack
Leukemia|December 1, 1991
Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T-cell receptor gene patternsC A Felix, D G Poplack
Medical Oncology (Northwood, London, England)|August 30, 2000
Neoplastic meningitis: diagnosis and treatment considerationsS M Blaney, D G Poplack
Cancer Research|November 1, 1981
Purine pathway enzyme abnormalities in acute lymphoblastic leukemiaD G Poplack, J Blatt, G Reaman
The New England Journal of Medicine|October 16, 1980
Current concepts. Biochemical markers in lymphoid malignancyJ Blatt, G Reaman, D G Poplack
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 7, 1999
Impact of nutrition on pharmacokinetics of anti-neoplastic agentsD J Murry, L Riva, D G Poplack
Pageof 23

Showing results (11-20 of 227) with videos related to

Sort By:
Pageof 23
Investigational New Drugs|January 1, 1996
Pharmacologic strategies for the treatment of meningeal malignancyS M Blaney, D G Poplack
Medical and Pediatric Oncology|January 1, 1979
Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoirW A Bleyer, D G Poplack
Current Opinion in Oncology|January 1, 1996
Central nervous system leukemiaS M Blaney, D G Poplack
Journal of Neuro-Oncology|August 8, 1998
New cytotoxic drugs for intrathecal administrationS M Blaney, D G Poplack
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Central nervous system pharmacology of antileukemic drugsF M Balis, D G Poplack
Leukemia|December 1, 1991
Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T-cell receptor gene patternsC A Felix, D G Poplack
Medical Oncology (Northwood, London, England)|August 30, 2000
Neoplastic meningitis: diagnosis and treatment considerationsS M Blaney, D G Poplack
Cancer Research|November 1, 1981
Purine pathway enzyme abnormalities in acute lymphoblastic leukemiaD G Poplack, J Blatt, G Reaman
The New England Journal of Medicine|October 16, 1980
Current concepts. Biochemical markers in lymphoid malignancyJ Blatt, G Reaman, D G Poplack
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 7, 1999
Impact of nutrition on pharmacokinetics of anti-neoplastic agentsD J Murry, L Riva, D G Poplack
Pageof 23